Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease

Journal of Internal Medicine

Volumn 262, Issue 6, 2007, Pages 690-701

  Carrero, J J ^a   Qureshi, A R ^a   Axelsson, J ^a   Yilmaz, M I ^a   Rehnmark, S ^b   Witt, M R ^b   Barany P ^b   Heimburger O ^a   Suliman, M E ^a   Alvestrand, A ^a   Lindholm, B ^a   Stenvinkel, P ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Karo Bio   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic kidney disease; Inflammation; Mortality; Triiodothyronine; Wasting

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LIOTHYRONINE; SERUM ALBUMIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; THYROID HORMONES; TRIIODOTHYRONINE; WASTING SYNDROME;

EID: 36248953130     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01865.x     Document Type: Article

References (43)

1. Chopra IJ. Nonthyroidal illness syndrome or euthyroid sick syndrome? Endocr Pract 1996 2 : 45 52.
2. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 1996 17 : 45 63.
3. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 2005 67 : 1047 52.
4. Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am 2002 31 : 173 89.
5. Manowitz NR, Mayor GH, Klepper MJ, DeGroot LJ. Subclinical Hypothyroidism and Euthyroid Sick Syndrome in Patients with Moderate-to-Severe Congestive Heart Failure. Am J Ther 1996 3 : 797 801.
6. Kozdag G, Ural D, Vural A et al. Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail 2005 7 : 113 8.
7. Iervasi G, Pingitore A, Landi P et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003 107 : 708 13.
8. Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990 16 : 91 5.
9. Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 2005 118 : 132 6.
10. Opie LH. Cellular basis for therapeutic choices in heart failure. Circulation 2004 110 : 2559 61.
11. Ozawa M, Sato K, Han DC, Kawakami M, Tsushima T, Shizume K. Effects of tumor necrosis factor-alpha/cachectin on thyroid hormone metabolism in mice. Endocrinology 1988 123 : 1461 7.
12. Torpy DJ, Tsigos C, Lotsikas AJ, Defensor R, Chrousos GP, Papanicolaou DA. Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans. Metabolism 1998 47 : 1289 93.
13. Bartalena L, Brogioni S, Grasso L, Velluzzi F, Martino E. Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest 1994 17 : 269 74.
14. Van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990 71 : 1567 72.
15. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999 55 : 1899 911.
16. Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol 2005 16 : 2789 95.
17. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int 2006 70 : 523 8.
18. Enia G, Panuccio V, Cutrupi S et al. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2007 22 : 538 44.
19. Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004 291 : 228 38.
20. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002 87 : 489 99.
21. Qureshi AR, Alvestrand A, Danielsson A et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998 53 : 773 82.
22. Detsky AS, McLaughlin JR, Baker JP et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987 11 : 8 13.
23. Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003 229 : 3 8.
24. Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 1993 77 : 1695 9.
25. Yu J, Koenig RJ. Regulation of hepatocyte thyroxine 5′-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem 2000 275 : 38296 301.
26. Qureshi AR, Alvestrand A, Divino-Filho JC et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002 13 (Suppl 1 S28 36.
27. Avesani CM, Carrero JJ, Axelsson J, Qureshi AR, Lindholm B, Stenvinkel P. Inflammation and wasting in chronic kidney disease: Partners in crime. Kidney Int Suppl 2006 70 : S8 13.
28. Heimburger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000 36 : 1213 25.
29. Iglesias P, Bayon C, Mendez J, Gancedo PG, Grande C, Diez JJ. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction. Thyroid 2001 11 : 1043 8.
30. Axelsson J, Qureshi AR, Divino-Filho JC et al. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease? Eur J Clin Nutr 2006 60 : 718 26.
31. Hussain MA, Schmitz O, Jorgensen JO et al. Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone. Eur J Endocrinol 1996 134 : 563 7.
32. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988 240 : 1285 93.
33. Peeters RP, Van der Geyten S, Wouters PJ et al. Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab 2005 90 : 6498 507.
34. Sonawane S, Kasbekar N, Berns JS. The safety of heparins in end-stage renal disease. Semin Dial 2006 19 : 305 10.
35. Squire CR. Methods for the investigation of thyroid function. Methods Mol Biol 2006 324 : 91 108.
36. Kilinc AS, Duzoylum A, Uncugil CF, Yucel D. Falsely increased free triiodothyronine in sera stored in serum separator tubes. Clin Chem 2002 48 : 2296 7.
37. Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis 2001 38 : S80 4.
38. Friberg L, Werner S, Eggertsen G, Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med 2002 162 : 1388 94.
39. Trivieri MG, Oudit GY, Sah R et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A 2006 103 : 6043 8.
40. Zoccali C, Benedetto F, Mallamaci F et al. Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertens 2006 24 : 2039 46.
41. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999 34 : 618 20.
42. Bartalena L. The dilemma of non-thyroidal illness syndrome: to treat or not to treat? J Endocrinol Invest 2003 26 : 1162.
43. Rosolowska-Huszcz D, Kozlowska L, Rydzewski A. Influence of low protein diet on nonthyroidal illness syndrome in chronic renal failure. Endocrine 2005 27 : 283 8.